Lower middle market private equity firm

Candescent Partners

At a glance

EBITDA range$2M+ S1
Revenue range$10M to $50M S1
Check size$10M to $30M S1
Deal typesPlatform, Add-on, Growth S1
SectorsHealthcare Services, Software & SaaS

What Candescent Partners buys

Candescent Partners is a Boston private equity firm founded in 2008 by Steve Jenks and Sandy McGrath. It backs founder-led companies in fragmented parts of healthcare services, business services, software, and consumer products and services. It looks for $10 million to $50 million of revenue, at least $2 million of EBITDA and a company value of $15 million to $75 million, and it invests $10 million to $30 million per deal.

In plain terms, Candescent ends up owning between half and all of a company, and it funds that stake with preferred equity, mezzanine debt or a mix of the two. It takes board seats and leaves daily operations to management. It has often led deals with co-investors, then built the company through add-on purchases. Its one remaining active platform is ENT Partners, an ear, nose and throat practice management company, so a smaller practice is most likely to meet Candescent as an add-on to it.

Recent deals

Announced in the 24 months before November 5, 2026.

DateCompanyTypeSectorSource
August 2026Imagine Technology GroupArizona office technology and managed IT company, known as ITG, acquired by DEX Imaging; the date is the announcement month given by DEXExitSource
Jun 2025ENT Specialists, LtdChicago suburbs ENT practice added to ENT Partners, its third purchase of 2025Add-onHealthcare ServicesSource
May 2025Currence Physician SolutionsMedical billing company added to ENT PartnersAdd-onHealthcare ServicesSource
Jan 2025Practice of Alan E. Oshinsky, MD, PA and The Hearing Wellness CenterTwo Baltimore businesses with five locations added to ENT PartnersAdd-onHealthcare ServicesSource

Portfolio by sector

From the firm's portfolio page S2.

Healthcare Services

  • ENT Partners

Past investments: Imagine Technology Group, Definiti, The Southeastern Spine Institute, Claris Vision, Dermatology Associates, Quadrant Software, SoftBase Systems, Candescent Healing

Greymont’s take

How Candescent Partners fits a seller

Candescent suits a founder of a healthcare services, business services or software company with at least $2 million of EBITDA who wants cash at closing and also a backer for a buy-and-build plan. Its deals start with one platform and add to it, as Definiti did in retirement plan services before its 2023 sale to Lovell Minnick Partners, and as ENT Partners is doing now. Daily control stays with management.

The structure deserves attention. Because Candescent invests through preferred equity, mezzanine debt or a blend, an owner who keeps shares should ask what Candescent is owed before those shares get paid. Physicians weighing a sale to ENT Partners should also ask how long Candescent plans to hold it, since no other active platform remains after the ITG sale.

Questions owners ask

How does Candescent Partners invest?

It puts $10 million to $30 million into each company through preferred equity, mezzanine debt or a blend of both, and its ownership ranges from 50% to 100%. That makes it a control investor, not a lender.

Is Candescent still buying companies?

Its recent buying has run through ENT Partners, which announced three purchases in 2025: Baltimore businesses in January, Currence Physician Solutions in May and ENT Specialists in June. No new Candescent platform was found in the last 24 months.

Does Candescent own ear, nose and throat practices?

Yes, through ENT Partners, a practice management company it lists as active. Both managing partners say they serve as directors there, and its practices sit in the Midwest and on the East Coast.

Who runs the business after Candescent invests?

Management does. Candescent takes board seats and offers advice and introductions, but it says daily operations stay with management no matter how much of the company it owns.

Sources

  1. S1Candescent Partners home page and investment criteria Accessed November 5, 2026
  2. S2Candescent Partners: Investments Accessed November 5, 2026
  3. S3Candescent Partners: Team Accessed November 5, 2026
  4. S4Candescent Partners: Contact Accessed November 5, 2026
  5. S5Candescent Partners: News Accessed November 5, 2026
  6. S6ENT Partners Acquisition Expands Footprint in Baltimore, MD (January 29, 2025) Accessed November 5, 2026
  7. S7ENT Partners: In the News (Currence, May 1, 2025; ENT Specialists, June 4, 2025; Chicago ENT Northwest, June 10, 2026) Accessed November 5, 2026
  8. S8DEX Imaging: ITG Arizona Is Now Part of DEX Imaging (November 4, 2026) Accessed November 5, 2026
  9. S9Candescent Partners Invests in the Southeastern Spine Institute (April 2017) Accessed November 5, 2026
  10. S10Candescent Partners Invests in Retirement Horizons (June 2015) Accessed November 5, 2026

Compiled by Greymont Advisors from public sources, including the firm’s own website and press releases. Greymont is not affiliated with Candescent Partners. Figures are as reported on the dates shown and may have changed. Request a correction

For business owners

Thinking about selling? Start here.

We work for the buyers, so owners never pay us a fee or a share of proceeds. See what your business could be worth and how many buyers fit a company like yours, or start a confidential conversation.